Quarterly Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7257216

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,263,628,000 JPY
-1,155,034,000 JPY
Interest and dividends received
60,000 JPY
13,000 JPY
Income taxes paid
-1,900,000 JPY
-1,900,000 JPY
Net cash provided by (used in) operating activities
-1,250,359,000 JPY
-1,156,920,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,370,000 JPY
-6,194,000 JPY
Net cash provided by (used in) investing activities
-1,370,000 JPY
-7,648,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
500,000,000 JPY
500,000,000 JPY
Redemption of bonds
-587,500,000 JPY
-387,500,000 JPY
Purchase of treasury shares
-2,000 JPY
JPY
Net cash provided by (used in) financing activities
1,004,840,000 JPY
690,959,000 JPY
Net increase (decrease) in cash and cash equivalents
-246,889,000 JPY
-473,609,000 JPY
Cash and cash equivalents
810,470,000 JPY
1,057,360,000 JPY
1,530,969,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.